Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.82)
# 3,336
Out of 5,090 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $32.02 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $19.93 | +244.96% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.67 | +319.16% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.66 | +2,187.98% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.84 | +19,465.22% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $104.60 | -66.54% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $23.00 | +117.39% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $5.17 | +29,300.39% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $6.91 | +1,419.54% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $35.38 | -18.03% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $6.50 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.02
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $19.93
Upside: +244.96%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.67
Upside: +319.16%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.66
Upside: +2,187.98%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.84
Upside: +19,465.22%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $104.60
Upside: -66.54%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $23.00
Upside: +117.39%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $5.17
Upside: +29,300.39%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $6.91
Upside: +1,419.54%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $35.38
Upside: -18.03%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $6.50
Upside: -